DVT complete diagnostic approach resident survival guide: Difference between revisions
Rim Halaby (talk | contribs) No edit summary |
Rim Halaby (talk | contribs) No edit summary |
||
Line 5: | Line 5: | ||
:❑ [[HACEK organism|HACEK group]]<BR> | :❑ [[HACEK organism|HACEK group]]<BR> | ||
:❑ Community-acquired [[staphylococcus aureus]] | :❑ Community-acquired [[staphylococcus aureus]] | ||
:❑[[Enterococci]] | :❑[[Enterococci]]<br> | ||
<br> | |||
OR | OR | ||
<br> | |||
* Microorganisms consistent with infective endocarditis from persistently positive blood cultures defined as:<BR> | * Microorganisms consistent with infective endocarditis from persistently positive blood cultures defined as:<BR> | ||
Line 55: | Line 55: | ||
:❑ Community-acquired [[staphylococcus aureus]] | :❑ Community-acquired [[staphylococcus aureus]] | ||
:❑[[Enterococci]] <br> | :❑[[Enterococci]] <br> | ||
<br>OR<br> | <br>OR<br><br> | ||
❑ Microorganisms consistent with infective endocarditis from persistently positive blood cultures defined as:<BR> | ❑ Microorganisms consistent with infective endocarditis from persistently positive blood cultures defined as:<BR> | ||
:❑ At least 2 positive cultures of blood samples drawn >12 hours apart, or<BR> | :❑ At least 2 positive cultures of blood samples drawn >12 hours apart, or<BR> | ||
:❑ All of 3 or a majority of 4 separate cultures of blood (with first and last sample drawn 1 hour apart)< | :❑ All of 3 or a majority of 4 separate cultures of blood (with first and last sample drawn 1 hour apart)<br> | ||
<br>OR<br><br> | |||
❑ Single positive blood culture for Coxiella burnetii or anti–phase 1 IgG antibody titer >1:800|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left <br> | ❑ Single positive blood culture for Coxiella burnetii or anti–phase 1 IgG antibody titer >1:800|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left <br> | ||
<br> | <br> | ||
Line 69: | Line 70: | ||
❑ Predisposing heart condition or intravenous drug use<BR> | ❑ Predisposing heart condition or intravenous drug use<BR> | ||
<br> | <br> | ||
'''2- Fever''' | '''2- Fever'''<br> | ||
❑ Temperature > 38.0° C (100.4° F)<BR> | ❑ Temperature > 38.0° C (100.4° F)<BR> | ||
<br> | <br> |
Revision as of 02:14, 5 March 2014
Positive Blood Culture for Infective Endocarditis
- Typical microorganism consistent with infective endocarditis from 2 separate blood cultures, in the absence of a primary focus:
- ❑ Viridans streptococci, streptococcus bovis
- ❑ HACEK group
- ❑ Community-acquired staphylococcus aureus
- ❑Enterococci
OR
- Microorganisms consistent with infective endocarditis from persistently positive blood cultures defined as:
- ❑ At least 2 positive cultures of blood samples drawn >12 hours apart, or
- ❑ All of 3 or a majority of 4 separate cultures of blood (with first and last sample drawn 1 hour apart)
- Single positive blood culture for Coxiella burnetii or anti–phase 1 IgG antibody titer >1:800
Echocardiographic evidence of endocardial involvement
- ❑ Oscillating intracardiac mass on valve or supporting structures, in the path of regurgitant jets, or on implanted material in the absence of an alternative anatomic explanation, or
- ❑ Abscess, or
- ❑ New partial dehiscence of prosthetic valve, or
- ❑ New valvular regurgitation
Minor criteria:
- Predisposition:
- ❑ Predisposing heart condition or intravenous drug use
- Fever:
- ❑ Temperature > 38.0° C (100.4° F)
- Vascular phenomena:
- ❑ Major arterial emboli
- ❑ Septic pulmonary infarcts
- ❑ Mycotic aneurysm
- ❑ Intracranial hemorrhage
- ❑ Conjunctival hemorrhage
- ❑ Janeway lesions
- Immunologic phenomena:
- Microbiological evidence:
- ❑ Positive blood culture but does not meet a major criterion as noted above, or
- ❑ Serological evidence of active infection with organism consistent with infectious endocarditis
Major criteria | Minor criteria |
1- Positive Blood Culture for Infective Endocarditis ❑ Typical microorganism consistent with infective endocarditis from 2 separate blood cultures, in the absence of a primary focus:
|
1- Predisposition ❑ Predisposing heart condition or intravenous drug use |